Valuation: AGP Limited

Market Cap 44.25B 160M 140M 132M 121M 226M 15.31B 227M 1.58B 614M 7.82B 600M 587M 25.14B P/E 2025 *
-
P/E 2026 * -
Enterprise Value 44.25B 160M 140M 132M 121M 226M 15.31B 227M 1.58B 614M 7.82B 600M 587M 25.14B EV / Sales 2025
1.97x
EV / Sales 2026 * 1.39x
Free-Float
30.43%
Yield 2025
3.94%
Yield 2026 * 3.15%
1 day+0.54%
1 week+5.21%
Current month-2.88%
1 month-8.20%
3 months-22.54%
6 months-17.87%
Current year-21.85%
1 week 152.5
Extreme 152.5
159
1 month 150
Extreme 150
171.99
Current year 150
Extreme 150
258.67
1 year 150
Extreme 150
258.67
3 years 48.26
Extreme 48.26
258.67
5 years 46
Extreme 46
258.67
10 years 46
Extreme 46
258.67
Manager TitleAgeSince
Chief Executive Officer - 2023-12-31
Director of Finance/CFO - 2016-11-30
Chief Tech/Sci/R&D Officer - 2023-07-31
Director TitleAgeSince
Chairman - 2015-06-02
Director/Board Member - 2015-11-29
Director/Board Member - 2015-11-29
Change 5-day change 1-year change 3-year change Capi.($)
+0.54%+5.21%-20.43%+211.29% 159M
+0.03%+2.26%+64.99%+113.47% 1,053B
+0.09%+0.21%+52.24%+68.83% 652B
-0.25%+0.12%+20.93%+70.88% 468B
-0.85%+0.98%+41.29%+44.38% 351B
+0.71%+4.08%+22.24%+29.51% 273B
+1.23%+0.42%+14.57%+12.13% 254B
+1.74%+6.89%+52.02%+54.48% 220B
-0.04%-0.18%+35.00%+100.23% 186B
0.00%-10.14%-29.94%-60.30% 170B
Average +0.29%+0.65%+25.29%+64.49% 362.75B
Weighted average by Cap. +0.12%+1.00%+41.19%+67.45%

Financials

2025 2026 *
Net sales 29.41B 106M 93.18M 88M 80.2M 150M 10.18B 151M 1.05B 408M 5.2B 399M 390M 16.71B 31.76B 115M 101M 95.03M 86.6M 162M 10.99B 163M 1.14B 440M 5.61B 431M 421M 18.04B
Net income - -
Net Debt - -
Logo AGP Limited
AGP Limited is a Pakistan-based pharmaceutical company. The principal activities of the Company include import, marketing, export, dealership, distribution, wholesale, and manufacturing of all kinds of pharmaceutical products. It owns a range of products catering to distinct therapeutic needs of the market. It offers a diverse portfolio of products in internal medicine, gynecology, pediatrics, nutraceutical, neuropsychiatry, cardiometabolic, hepatology, and orthopedic. Its products include Afdol, Nebcin, Exotan, Nergab, Febuxin, Zerifax, Protege, Maxna, Lucast, Urso, Kefzol, Algocin, Poze, Analar, Magnus MR, Novafol, Vita-NEM Plus, Colidrop, Daplazole, Lipomax, Rigix, and others. Its subsidiaries include OBS AGP (Private) Limited (OBS AGP) and OBS Pakistan (Private), which are in the business of trading pharmaceutical products.
Employees
2,143
Date Price Change Volume
26-09-24 PKR 158.76 +0.54% 85,995
26-09-24 PKR 157.90 +1.17% 288,353
26-09-23 PKR 156.08 +2.03% 326,873
26-09-22 PKR 152.98 -0.01% 96,597
26-09-21 PKR 153.00 -0.23% 122,341
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
158.76PKR
Average target price
246.40PKR
Spread / Average Target
+55.20%

Quarterly revenue - Rate of surprise